DrugCard

DrugCard

Verified
4.1
11 saves
Updated November 18, 2026

Drug safety teams monitor local medical journals often missed by global databases.

Key Takeaways

What it is
Drug safety teams monitor local medical journals often missed by global databases.
Pricing
Freemium
Best for
  • Global and local literature monitoring
  • AI Agent for Literature Monitoring
  • AI article analysis
Rating
4.1/5

What is DrugCard?

DrugCard monitors medical literature for pharmaceutical companies, contract research organizations, and pharmacovigilance specialists who need to find drug safety information across countries. Its AI helps screen articles, summarize findings, and organize safety-related work. The aim is to reduce time spent sorting through publications while keeping decisions reviewable.

DrugCard’s standout strength is its reach into local medical journals that global databases may miss. The company says it monitors more than 2,300 local journals across 151 countries and supports more than 100 languages. That makes it especially relevant when a drug safety team needs visibility beyond English-language or widely indexed research.

Drug safety teams at marketing authorization holders, contract research organizations, and independent pharmacovigilance providers are the clearest fit. AI-generated assessments and case details still require specialist review, so DrugCard does not remove expert responsibility. It is built for regulated literature-monitoring work, not general-purpose research or everyday writing.

Who is Using DrugCard?

Pharmacovigilance Specialists

Article relevance indicators, summaries, and structured notes help specialists prioritize publications and document assessments.

Pharmacovigilance Project Managers

Project-level monitoring and audit records help managers follow screening work across products and markets.

Qualified Persons for Pharmacovigilance

Traceable screening records can support oversight of literature monitoring and safety processes.

Regulatory Affairs Specialists

The Regulatory Intelligence module helps track regulatory updates and review AI summaries of source documents.

Uncommon Use Cases

Preparing literature search evidence for aggregate safety reports; tracking regulatory updates for impact assessment

Key Features

Global and local literature monitoring: Scheduled searches cover sources such as PubMed and Embase, alongside local journals that may not appear in global databases.
AI Agent for Literature Monitoring: The agent can screen for pharmacovigilance relevance, assess product relevance, and apply safety categories at configurable automation levels.
AI article analysis: AI relevance indicators, summaries, and structured case details help specialists prioritize articles and review key information.
AI-generated notes: Draft notes organize article details around the patient, product, reaction, and special situations for a specialist to review.
Integrated case creation: Extracted patient, product, and reaction details can prefill a draft Individual Case Safety Report in the DrugCard safety database.
Audit trail: Recorded actions and AI Agent runs help teams trace screening and categorization decisions.

Rating Breakdown

4.1/ 5.0
accuracy
4.3
ease of use
4.0
features
4.4
speed
4.2
support
3.8
value
3.8

Pricing Plans

Free Tier

Free

  • Experience DrugCard with a trial period customized upon request

Which DrugCard plan should you pick?

Start with the free two-week trial to test your monitoring workflow, then contact DrugCard to discuss a suitable paid setup.

DrugCard Use Cases

Screening local medical literature

Local-language journal monitoring brings safety-relevant publications into the same review process as global sources.

Outcome: Broader visibility into publications that may be missed by global databases.

Prioritizing article reviews

AI relevance indicators and summaries help specialists decide which publications need closer attention.

Outcome: Less time spent reading articles that are unlikely to be relevant.

Preparing safety case drafts

Structured AI extraction can carry patient, product, and reaction details into a draft case for specialist review.

Outcome: A partially completed Individual Case Safety Report draft.

Tracking regulatory updates

A searchable newsfeed and AI summaries help teams review updates from monitored regulatory sources.

Outcome: Regulatory updates collected for review and impact assessment.

Supporting aggregate reports

Documented literature searches and relevant references can support PSUR, PBRER, and DSUR preparation.

Outcome: Exportable search results and references with an audit trail.

Workflow Ideas with DrugCard

Review a new safety article

  1. 1Monitor configured global and local literature sources.
  2. 2Sort new articles using AI relevance indicators and summaries.
  3. 3Review the source and confirm the article’s category.

Prepare a literature-based case

  1. 1Open an article flagged for safety review.
  2. 2Check the extracted patient, product, and reaction details against the source.
  3. 3Create and complete the safety case draft.

Track a regulatory update

  1. 1Monitor selected regulatory authorities and topics.
  2. 2Review an update with its AI summary and source document.
  3. 3Save it with notes for an impact assessment.

How DrugCard fits into your stack

Literature monitoring

DrugCard searches global sources such as PubMed and Embase, as well as configured local journals. Results are collected for review in the platform.

Article review

AI indicators, summaries, and structured data support screening inside the article review workflow. Specialists remain responsible for checking and confirming the results.

Safety case processing

Literature analysis can feed a draft Individual Case Safety Report in DrugCard’s Adverse Reactions database.

Regulatory intelligence

The Regulatory Intelligence module provides searchable updates and an API for sending information to a company’s compliance systems.

Reporting and audit records

Documented searches, exports, and audit trails support aggregate reporting and traceability.

Pros

  • +Local journal coverage: Monitors regional and non-indexed medical publications that global databases may not include.
  • +Language reach: Supports literature screening across more than 100 languages.
  • +Human review: AI outputs are presented for specialist review rather than silently becoming official records.
  • +Connected case workflow: Article analysis can help prefill a safety case draft in DrugCard’s database.

Cons

  • −Specialized scope: The platform is aimed at pharmacovigilance literature and drug safety work, not general research.
  • −Pricing is not listed: You need to contact DrugCard to discuss platform pricing.
  • −Setup takes planning: Adding journals for a new country typically takes about two to three weeks.

Limitations & when to consider alternatives

Known limitations

  • New journal coverage takes time. DrugCard says adding a new set of journals for a country typically takes about two to three weeks, depending on the country and number of journals.
  • AI results need specialist review. DrugCard describes AI assessments and extracted information as decision support that specialists should check and confirm.
  • No public plan prices. The site directs prospective customers to contact the company about tariff plans and pricing.

Look elsewhere when

  • You need a general-purpose AI tool for work outside pharmacovigilance.
  • Your team needs a self-service subscription with publicly listed prices.

How to Use DrugCard

  1. 1

    Request a demonstration or trial

    Contact DrugCard to discuss the platform, a free two-week trial, and the monitoring needs of your team.

  2. 2

    Set up users and access

    Define user roles and responsibilities so each person has an account with traceable activity.

  3. 3

    Configure monitoring projects

    Set up the products, countries, sources, and search needs for each project.

  4. 4

    Choose an AI Agent level

    For supported projects, select the level of screening and categorization automation that fits your review process.

  5. 5

    Review and confirm AI outputs

    Check article assessments, notes, and extracted case details against the source before saving or acting on them.

  6. 6

    Use the records for reporting

    Export documented search results and relevant references for aggregate reports or audits.

Who is DrugCard For?

Contract Research Organizations

CROs can manage literature-monitoring work across client projects and markets with documented screening workflows.

Marketing Authorization Holders

Pharmaceutical companies can monitor local and global literature for their products and keep screening records together.

Freelance Pharmacovigilance Providers

Independent specialists can reduce manual article screening time and focus on higher-value safety work.

Frequently Asked Questions

Is there a free trial?

DrugCard’s site offers a free two-week trial. Contact the company to discuss access.

How much does DrugCard cost?

The company does not list platform prices publicly. Contact DrugCard for pricing based on your project.

Can DrugCard monitor local journals in other languages?

Yes. DrugCard says it supports more than 100 languages and monitors local medical journals across many countries.

Does DrugCard create safety cases automatically?

AI can extract case details and help create a draft, but specialists are expected to review and complete the case.

Can DrugCard connect with other systems?

The Regulatory Intelligence module offers API access to send updates to a company’s compliance systems.

Community reviews

Be the first to share your experience.

Sign in to leave a review for DrugCard.

No reviews yet. Yours could be the first.

DrugCard Alternatives

Looking for alternatives to DrugCard? Here are similar tools in the same category:

DrugCard screenshot
Free Trial